Phenylketonuria Market to Reach New Heights by 2034, Driven by Innovative Therapies and Rising Diagnosis Rates | DelveInsight

Recently published Phenylketonuria Market Insights report includes a comprehensive understanding of current treatment ...

Ivanhoe Mines Ltd.: Ivanhoe Mines Issues 2025 Fourth Quarter and Annual Financial Results

Ivanhoe Mines reports profit of $228M and adjusted EBITDA of $578M for 2025Kamoa-Kakula generates 2025 revenue of $3.28B and EBITDA of $1.45B, at a margin of 44%, despite lower production and sales ...

DelveInsight Business Research, LLP: Phenylketonuria Market to Reach New Heights by 2034, Driven by Innovative Therapies and Rising Diagnosis Rates | DelveInsight

NGGT002 (NGGT), JNT-517 (Jnana Therapeutics), Pegvaliase (BioMarin), and others under investigation, the phenylketonuria ...
Goldseiten

Ivanhoe Mines Issues 2025 Fourth Quarter and Annual Financial Results

Ivanhoe Mines reports profit of $228M and adjusted EBITDA of $578M for 2025 Kamoa-Kakula generates 2025 revenue of $3.28B and ...